259 LIBERTY AVENUE, STATEN ISLAND, NY
Material Contracts, Unregistered Sales of Equity Securities, Other Events
Acurx Announces Ibezapolstat Trial for Recurrent CDI Treatment
News, Articles of Incorporation
Shareholder votes
Announces Reverse Stock Split
Announces Exercise of Warrants for $2.67 Million Gross Proceeds
Annual Report to Security Holders
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement